SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-22-004027
Filing Date
2022-02-11
Accepted
2022-02-11 16:30:32
Documents
2
Group Members
G.YAROM MEDICAL RESEARCH LTD.

Document Format Files

Seq Description Document Type Size
1 formsc13ga.htm SC 13G/A 89806
2 ex-a.htm EX-1 8168
  Complete submission text file 0001493152-22-004027.txt   99313
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Subject) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88495 | Film No.: 22621617
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GALMED PHARMACEUTICALS,8 SHAUL HAMELECH BLVD., AMOT HAMISHPAT BLDG. TEL AVIV L3 64733
Business Address
Baharaff Allen (Filed by) CIK: 0001630334 (see all company filings)

Type: SC 13G/A